Archive for June 15th, 2009

The Earth’s magnetic field remains a charged mystery

Professor Gregory Ryskin from the McCormick School of Engineering and Applied Science at Northwestern University in Illinois, US, has defied the long-standing convention by applying equations from magnetohydrodynamics to our oceans’ salt water (which conducts electricity) and found that the long-term changes (the secular variation) in the Earth’s main magnetic field are possibly induced by our oceans’ circulation.

More: continued here

Monday, June 15th, 2009

Tracking levels of key biomarkers reflects disease activity and progression o…

New research has identified biomarkers associated with inflammation and progression in joint erosion in individuals with early rheumatoid arthritis, according to the results of a new study presented today at EULAR 2009, the Annual Congress of the European League Against Rheumatism in Copenhagen, Denmark.

More: continued here

Monday, June 15th, 2009

Increased levels of certain cytokines and chemokines predict onset of rheumat…

Up-regulation of certain cytokines and chemokines (signaling molecules involved in the functioning of the immune system) can predict the development of rheumatoid arthritis three years before the onset of symptoms, according to the results of a new study presented today at EULAR 2009, the Annual Congress of the European League Against Rheumatism in Copenhagen, Denmark.

More: continued here

Monday, June 15th, 2009

Canakinumab shows promising efficacy and tolerability in children with system…

Canakinumab, a new interleukin-1-beta blocking monoclonal antibody, shows encouraging efficacy and is well tolerated in children with systemic juvenile idiopathic arthritis, according to a new phase II study presented today at PReS 2009, a joint congress with the 2009 Congress of the European League Against Rheumatism in Copenhagen, Denmark.

More: continued here

Monday, June 15th, 2009

Research holds promise for novel oral anti-diabetic drugs

Promise is held out for the development of novel oral drugs to control blood glucose levels in diabetes patients as the result of research by a Hebrew University of Jerusalem scientist.

More: continued here

Monday, June 15th, 2009

Study suggests new approach to common cause of blindness

Researchers at the University of North Carolina at Chapel Hill School of Medicine in collaboration with lead investigators at the University of Kentucky have identified a new target for the diagnosis and treatment of age-related macular degeneration, the most common cause of blindness in older Americans.

More: continued here

Monday, June 15th, 2009

The dark side of gifts: Feeling indebted may drive people to the marketplace

You need to move out of your apartment. Do you call in your friends and family to haul boxes and furniture or contact a moving company? A new study in the Journal of Consumer Research shows that sometimes the emotions connected with asking for favors can actually drive people to the market.

More: continued here

Monday, June 15th, 2009

The complicated consumer: Positive ads aren’t always the most effective

Ads that feature positive emotions, like happiness, are not always the best way to reach consumers, according to a new study in the Journal of Consumer Research.

More: continued here

Monday, June 15th, 2009

Chemical in blood may explain susceptibility to bladder pain

A marker in the blood of both cats and humans that was identified in a recent study might signal both species’ susceptibility for a painful bladder disorder called interstitial cystitis, a condition that is often difficult to diagnose.

More: continued here

Monday, June 15th, 2009

New method separates cancer cells from normal cells

Northwestern University researchers have demonstrated a novel and simple method that can direct and separate cancer cells from normal cells. The device, which takes advantage of a physical principle called ratcheting, is a very tiny system of channels for cell locomotion. Based on this method, they have proposed that cancer cells possibly could be sequestered permanently in a sort of “cancer trap” made of implantable and biodegradable materials.

More: continued here

Monday, June 15th, 2009